James T. Craig, D.D.S.; Decision and Order, 9169-9170 [2025-02341]
Download as PDF
Federal Register / Vol. 90, No. 25 / Friday, February 7, 2025 / Notices
pursuant to 28 CFR 0.100(b) and the
authority vested in me by 21 U.S.C.
823(g)(1), I hereby deny any pending
applications of Herold Pierre-Louis,
P.A., to renew or modify this
registration, as well as any other
pending application of Herold PierreLouis, P.A., for additional registration in
Arizona. This Order is effective March
10, 2025.
Signing Authority
This document of the Drug
Enforcement Administration was signed
on January 31, 2025, by Acting
Administrator Derek Maltz. That
document with the original signature
and date is maintained by DEA. For
administrative purposes only, and in
compliance with requirements of the
Office of the Federal Register, the
undersigned DEA Federal Register
Liaison Officer has been authorized to
sign and submit the document in
electronic format for publication, as an
official document of DEA. This
administrative process in no way alters
the legal effect of this document upon
publication in the Federal Register.
Heather Achbach,
Federal Register Liaison Officer, Drug
Enforcement Administration.
[FR Doc. 2025–02339 Filed 2–6–25; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
James T. Craig, D.D.S.; Decision and
Order
lotter on DSK11XQN23PROD with NOTICES1
On May 24, 2023, the Drug
Enforcement Administration (DEA or
Government) issued an Order to Show
Cause (OSC) to James T. Craig, D.D.S.,
of Aurora, Colorado (Registrant).
Request for Final Agency Action
(RFAA), Exhibit (RFAAX) 2, at 1, 3. The
OSC proposed the revocation of
Registrant’s Certificate of Registration
No. FC0032348, alleging that
Registrant’s registration should be
revoked because Registrant is ‘‘currently
without authority to prescribe,
administer, dispense, or otherwise
handle controlled substances in
Colorado, the state in which [he is]
registered with DEA.’’ Id. at 2 (citing 21
U.S.C. 824(a)(3)).1
1 According to Agency records, Registrant’s
registration expired on August 31, 2024. The fact
that a registrant allows his registration to expire
during the pendency of an OSC does not impact the
Agency’s jurisdiction or prerogative under the
Controlled Substances Act (CSA) to adjudicate the
OSC to finality. Jeffrey D. Olsen, M.D., 84 FR 68474,
68476–79 (2019).
VerDate Sep<11>2014
16:22 Feb 06, 2025
Jkt 265001
The OSC notified Registrant of his
right to file a written request for hearing,
and that if he failed to file such a
request, he would be deemed to have
waived his right to a hearing and be in
default. Id. at 2 (citing 21 CFR 1301.43).
Here, Registrant did not request a
hearing. RFAA, at 2.2 ‘‘A default, unless
excused, shall be deemed to constitute
a waiver of the registrant’s/applicant’s
right to a hearing and an admission of
the factual allegations of the [OSC].’’ 21
CFR 1301.43(e).
Further, ‘‘[i]n the event that a
registrant . . . is deemed to be in
default . . . DEA may then file a request
for final agency action with the
Administrator, along with a record to
support its request. In such
circumstances, the Administrator may
enter a default final order pursuant to
[21 CFR] § 1316.67.’’ Id. § 1301.43(f)(1).
Here, the Government has requested
final agency action based on Registrant’s
default pursuant to 21 CFR 1301.43(c),
(f), 1301.46. RFAA, at 3; see also 21 CFR
1316.67.
Findings of Fact
The Agency finds that, in light of
Registrant’s default, the factual
allegations in the OSC are admitted.
According to the OSC, on March 23,
2023, Registrant’s Colorado dental
license was suspended. RFAAX 2, at 1–
2. According to Colorado online records,
of which the Agency takes official
notice, Registrant’s Colorado dentist
license is revoked.3 Colorado Division
of Professions and Occupations License
Search, https://apps2.colorado.gov/
dora/licensing/lookup/licenselookup.
aspx (last visited date of signature of
this Order).
2 Based on the Government’s submissions in its
RFAA dated July 18, 2024, the Agency finds that
service of the OSC on Registrant was adequate.
Specifically, the included Declaration from a DEA
Diversion Investigator (DI) indicates that on May 26,
2023, Registrant was personally served a copy of the
OSC at the Arapahoe County Detention Center in
Centennial, Colorado, where Registrant remained
incarcerated. RFAAX 3, at 2.
3 Under the Administrative Procedure Act, an
agency ‘‘may take official notice of facts at any stage
in a proceeding—even in the final decision.’’
United States Department of Justice, Attorney
General’s Manual on the Administrative Procedure
Act 80 (1947) (Wm. W. Gaunt & Sons, Inc., Reprint
1979). Pursuant to 5 U.S.C. 556(e), ‘‘[w]hen an
agency decision rests on official notice of a material
fact not appearing in the evidence in the record, a
party is entitled, on timely request, to an
opportunity to show the contrary.’’ Accordingly,
Registrant may dispute the Agency’s finding by
filing a properly supported motion for
reconsideration of findings of fact within fifteen
calendar days of the date of this Order. Any such
motion and response shall be filed and served by
email to the other party and to the DEA Office of
the Administrator, Drug Enforcement
Administration at dea.addo.attorneys@dea.gov.
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
9169
Accordingly, the Agency finds that
Registrant is not licensed to practice as
a dentist in Colorado, the state in which
he is registered with DEA.
Discussion
Pursuant to 21 U.S.C. 824(a)(3), the
Attorney General is authorized to
suspend or revoke a registration issued
under 21 U.S.C. 823 ‘‘upon a finding
that the registrant . . . has had his State
license or registration suspended . . .
[or] revoked . . . by competent State
authority and is no longer authorized by
State law to engage in the . . .
dispensing of controlled substances.’’
With respect to a practitioner, DEA has
also long held that the possession of
authority to dispense controlled
substances under the laws of the state in
which a practitioner engages in
professional practice is a fundamental
condition for obtaining and maintaining
a practitioner’s registration. Gonzales v.
Oregon, 546 U.S. 243, 270 (2006) (‘‘The
Attorney General can register a
physician to dispense controlled
substances ‘if the applicant is
authorized to dispense . . . controlled
substances under the laws of the State
in which he practices.’ . . . The very
definition of a ‘practitioner’ eligible to
prescribe includes physicians ‘licensed,
registered, or otherwise permitted, by
the United States or the jurisdiction in
which he practices’ to dispense
controlled substances. § 802(21).’’). The
Agency has applied these principles
consistently. See, e.g., James L. Hooper,
M.D., 76 FR 71371, 71372 (2011), pet.
for rev. denied, 481 F. App’x 826 (4th
Cir. 2012); Frederick Marsh Blanton,
M.D., 43 FR 27616, 27617 (1978).4
According to Colorado statute,
‘‘dispense’’ means ‘‘to deliver a
controlled substance to an ultimate user,
4 This rule derives from the text of two provisions
of the CSA. First, Congress defined the term
‘‘practitioner’’ to mean ‘‘a physician . . . or other
person licensed, registered, or otherwise permitted,
by . . . the jurisdiction in which he practices . . . ,
to distribute, dispense, . . . [or] administer . . . a
controlled substance in the course of professional
practice.’’ 21 U.S.C. 802(21). Second, in setting the
requirements for obtaining a practitioner’s
registration, Congress directed that ‘‘[t]he Attorney
General shall register practitioners . . . if the
applicant is authorized to dispense . . . controlled
substances under the laws of the State in which he
practices.’’ 21 U.S.C. 823(g)(1). Because Congress
has clearly mandated that a practitioner possess
state authority in order to be deemed a practitioner
under the CSA, DEA has held repeatedly that
revocation of a practitioner’s registration is the
appropriate sanction whenever he is no longer
authorized to dispense controlled substances under
the laws of the state in which he practices. See, e.g.,
James L. Hooper, M.D., 76 FR 71371–72; Sheran
Arden Yeates, M.D., 71 FR 39130, 39131 (2006);
Dominick A. Ricci, M.D., 58 FR 51104, 51105
(1993); Bobby Watts, M.D., 53 FR 11919, 11920
(1988); Frederick Marsh Blanton, M.D., 43 FR
27617.
E:\FR\FM\07FEN1.SGM
07FEN1
9170
Federal Register / Vol. 90, No. 25 / Friday, February 7, 2025 / Notices
patient, or research subject by or
pursuant to the lawful order of a
practitioner, including the prescribing,
administering, packaging, labeling, or
compounding necessary to prepare the
substance for that delivery.’’ Colo. Rev.
Stat. section 18–18–102(9) (2024).
Further, a ‘‘practitioner’’ means a
‘‘physician . . . or other person
licensed, registered, or otherwise
permitted, by this state, to distribute,
dispense, conduct research with respect
to, administer, or to use in teaching or
chemical analysis, a controlled
substance in the course of professional
practice or research.’’ Id. section 18–18–
102(29).
Here, the undisputed evidence in the
record is that Registrant lacks authority
to practice as a dentist in Colorado. As
discussed above an individual must be
a licensed practitioner to dispense a
controlled substance in Colorado. Thus,
because Registrant lacks authority to
practice as a dentist in Colorado and,
therefore, is not authorized to handle
controlled substances in Colorado,
Registrant is not eligible to maintain a
DEA registration. Accordingly, the
Agency will order that Registrant’s DEA
registration be revoked.
Order
Pursuant to 28 CFR 0.100(b) and the
authority vested in me by 21 U.S.C.
824(a), I hereby revoke DEA Certificate
of Registration No. FC0032348, issued to
James T. Craig, D.D.S. Further, pursuant
to 28 CFR 0.100(b) and the authority
vested in me by 21 U.S.C. 823(g)(1), I
hereby deny any pending applications
of James T. Craig, D.D.S., to renew or
modify this registration, as well as any
other pending application of James T.
Craig, D.D.S., for additional registration
in Colorado. This Order is effective
March 10, 2025.
lotter on DSK11XQN23PROD with NOTICES1
Signing Authority
This document of the Drug
Enforcement Administration was signed
on January 31, 2025, by Acting
Administrator Derek Maltz. That
document with the original signature
and date is maintained by DEA. For
administrative purposes only, and in
compliance with requirements of the
Office of the Federal Register, the
undersigned DEA Federal Register
Liaison Officer has been authorized to
sign and submit the document in
electronic format for publication, as an
official document of DEA. This
administrative process in no way alters
VerDate Sep<11>2014
16:22 Feb 06, 2025
Jkt 265001
the legal effect of this document upon
publication in the Federal Register.
Heather Achbach,
Federal Register Liaison Officer, Drug
Enforcement Administration.
[FR Doc. 2025–02341 Filed 2–6–25; 8:45 am]
BILLING CODE 4410–09–P
NATIONAL SCIENCE FOUNDATION
Sunshine Act Meetings
The National Science Board’s
Committee on Awards and Facilities
(A&F) hereby gives notice of the
scheduling of meetings for the
transaction of National Science Board
business pursuant to the National
Science Foundation Act and the
Government in the Sunshine Act.
TIME AND DATE: The A&F meeting will be
held on Monday, February 10, 2025.
The open session will be from 2:30
p.m.–3:00 p.m. The closed session will
be from 3:00 p.m.–5:00 p.m.
PLACE: The meetings will be held at NSF
headquarters, 2145 Eisenhower Ave.,
Alexandria, VA 22314, and by
videoconference.
STATUS: One session is open, and one
session is closed.
MATTERS TO BE CONSIDERED:
A&F open session agenda: Opening
Remarks; Information Item: Summit
Station Recapitalization.
A&F closed session agenda: Opening
Remarks regarding the agenda;
Discussion and Vote: National Radio
Astronomy Observatory Operations and
Maintenance Award Authorization
Level Increase; Context Item: Mid-scale
Research Infrastructure Program Track
2; Context Item: National Geophysical
Facility.
CONTACT PERSON FOR MORE INFORMATION:
Point of contact for this meeting is:
Michelle McCrackin, mmccrack@
nsf.gov, (703) 292–7000. Members of the
public can observe the public portion of
this meeting through a YouTube
livestream: https://youtube.com/live/
45FMoMrZar8?feature=share.
Ann E. Bushmiller,
Senior Legal Counsel to the National Science
Board.
[FR Doc. 2025–02403 Filed 2–5–25; 11:15 am]
BILLING CODE 7555–01–P
NEIGHBORHOOD REINVESTMENT
CORPORATION
2:00 p.m., Thursday,
February 18, 2025.
PO 00000
Frm 00038
Fmt 4703
Sfmt 9990
STATUS:
Agenda
I. Call to Order
II. Sunshine Act Approval of Executive
(Closed) Session
III. Executive Session: CEO Report
IV. Executive Session: CFO Report
V. Executive Session: General Counsel
Report
VI. Executive Session: CIO Report
VII. Action Item: Approval of Meeting
Minutes for December 19 Regular
Board Meeting
VIII. Action Item: Resolution of
Recognition of Service for Former
FDIC Chairman Gruenberg
IX. Action Item: Resolution of
Recognition of Service for Former
Acting HUD Secretary Todman
X. Discussion Item: National
NeighborWorks Association
Presentation
XI. Discussion Item: Capital
Corporations Presentation
XII. Discussion Item: Health Insurance
Delegation of Authority
XIII. Discussion Item: Professional
Learning and Event Planning
Management System (PLEMS)
XIV. Discussion Item: Management
Program Background and Updates
a. 2025 Board Calendar
b. 2025 Board Agenda Planner
c. CFO Report
i. Financials (through 11/30/24)
ii. Single Invoice Approvals $100K
and over
iii. Vendor Payments $350K and over
iv. Exceptions
d. Housing Stability Counseling
Program (HSCP)
e. Strategic Plan Scorecard—FY24 Q4
(With Q4 Production)
PORTIONS OPEN TO THE PUBLIC:
Everything except the Executive
(Closed) Session.
PORTIONS CLOSED TO THE PUBLIC:
Executive (Closed) Session.
CONTACT PERSON FOR MORE INFORMATION:
Jenna Sylvester, Paralegal, (202) 568–
2560; jsylvester@nw.org.
Jenna Sylvester,
Paralegal.
Sunshine Act Meetings
TIME AND DATE:
via ZOOM.
Parts of this meeting will be
open to the public. The rest of the
meeting will be closed to the public.
MATTERS TO BE CONSIDERED: Regular
Board of Directors meeting.
The General Counsel of the
Corporation has certified that in her
opinion, one or more of the exemptions
set forth in the Government in the
Sunshine Act, 5 U.S.C. 552b(c)(2)
permit closure of the following
portion(s) of this meeting:
• Executive (Closed) Session
PLACE:
[FR Doc. 2025–02391 Filed 2–5–25; 11:15 am]
BILLING CODE 7570–01–P
E:\FR\FM\07FEN1.SGM
07FEN1
Agencies
[Federal Register Volume 90, Number 25 (Friday, February 7, 2025)]
[Notices]
[Pages 9169-9170]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-02341]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
James T. Craig, D.D.S.; Decision and Order
On May 24, 2023, the Drug Enforcement Administration (DEA or
Government) issued an Order to Show Cause (OSC) to James T. Craig,
D.D.S., of Aurora, Colorado (Registrant). Request for Final Agency
Action (RFAA), Exhibit (RFAAX) 2, at 1, 3. The OSC proposed the
revocation of Registrant's Certificate of Registration No. FC0032348,
alleging that Registrant's registration should be revoked because
Registrant is ``currently without authority to prescribe, administer,
dispense, or otherwise handle controlled substances in Colorado, the
state in which [he is] registered with DEA.'' Id. at 2 (citing 21
U.S.C. 824(a)(3)).\1\
---------------------------------------------------------------------------
\1\ According to Agency records, Registrant's registration
expired on August 31, 2024. The fact that a registrant allows his
registration to expire during the pendency of an OSC does not impact
the Agency's jurisdiction or prerogative under the Controlled
Substances Act (CSA) to adjudicate the OSC to finality. Jeffrey D.
Olsen, M.D., 84 FR 68474, 68476-79 (2019).
---------------------------------------------------------------------------
The OSC notified Registrant of his right to file a written request
for hearing, and that if he failed to file such a request, he would be
deemed to have waived his right to a hearing and be in default. Id. at
2 (citing 21 CFR 1301.43). Here, Registrant did not request a hearing.
RFAA, at 2.\2\ ``A default, unless excused, shall be deemed to
constitute a waiver of the registrant's/applicant's right to a hearing
and an admission of the factual allegations of the [OSC].'' 21 CFR
1301.43(e).
---------------------------------------------------------------------------
\2\ Based on the Government's submissions in its RFAA dated July
18, 2024, the Agency finds that service of the OSC on Registrant was
adequate. Specifically, the included Declaration from a DEA
Diversion Investigator (DI) indicates that on May 26, 2023,
Registrant was personally served a copy of the OSC at the Arapahoe
County Detention Center in Centennial, Colorado, where Registrant
remained incarcerated. RFAAX 3, at 2.
---------------------------------------------------------------------------
Further, ``[i]n the event that a registrant . . . is deemed to be
in default . . . DEA may then file a request for final agency action
with the Administrator, along with a record to support its request. In
such circumstances, the Administrator may enter a default final order
pursuant to [21 CFR] Sec. 1316.67.'' Id. Sec. 1301.43(f)(1). Here,
the Government has requested final agency action based on Registrant's
default pursuant to 21 CFR 1301.43(c), (f), 1301.46. RFAA, at 3; see
also 21 CFR 1316.67.
Findings of Fact
The Agency finds that, in light of Registrant's default, the
factual allegations in the OSC are admitted. According to the OSC, on
March 23, 2023, Registrant's Colorado dental license was suspended.
RFAAX 2, at 1-2. According to Colorado online records, of which the
Agency takes official notice, Registrant's Colorado dentist license is
revoked.\3\ Colorado Division of Professions and Occupations License
Search, https://apps2.colorado.gov/dora/licensing/lookup/licenselookup.aspx (last visited date of signature of this Order).
---------------------------------------------------------------------------
\3\ Under the Administrative Procedure Act, an agency ``may take
official notice of facts at any stage in a proceeding--even in the
final decision.'' United States Department of Justice, Attorney
General's Manual on the Administrative Procedure Act 80 (1947) (Wm.
W. Gaunt & Sons, Inc., Reprint 1979). Pursuant to 5 U.S.C. 556(e),
``[w]hen an agency decision rests on official notice of a material
fact not appearing in the evidence in the record, a party is
entitled, on timely request, to an opportunity to show the
contrary.'' Accordingly, Registrant may dispute the Agency's finding
by filing a properly supported motion for reconsideration of
findings of fact within fifteen calendar days of the date of this
Order. Any such motion and response shall be filed and served by
email to the other party and to the DEA Office of the Administrator,
Drug Enforcement Administration at [email protected].
---------------------------------------------------------------------------
Accordingly, the Agency finds that Registrant is not licensed to
practice as a dentist in Colorado, the state in which he is registered
with DEA.
Discussion
Pursuant to 21 U.S.C. 824(a)(3), the Attorney General is authorized
to suspend or revoke a registration issued under 21 U.S.C. 823 ``upon a
finding that the registrant . . . has had his State license or
registration suspended . . . [or] revoked . . . by competent State
authority and is no longer authorized by State law to engage in the . .
. dispensing of controlled substances.'' With respect to a
practitioner, DEA has also long held that the possession of authority
to dispense controlled substances under the laws of the state in which
a practitioner engages in professional practice is a fundamental
condition for obtaining and maintaining a practitioner's registration.
Gonzales v. Oregon, 546 U.S. 243, 270 (2006) (``The Attorney General
can register a physician to dispense controlled substances `if the
applicant is authorized to dispense . . . controlled substances under
the laws of the State in which he practices.' . . . The very definition
of a `practitioner' eligible to prescribe includes physicians
`licensed, registered, or otherwise permitted, by the United States or
the jurisdiction in which he practices' to dispense controlled
substances. Sec. 802(21).''). The Agency has applied these principles
consistently. See, e.g., James L. Hooper, M.D., 76 FR 71371, 71372
(2011), pet. for rev. denied, 481 F. App'x 826 (4th Cir. 2012);
Frederick Marsh Blanton, M.D., 43 FR 27616, 27617 (1978).\4\
---------------------------------------------------------------------------
\4\ This rule derives from the text of two provisions of the
CSA. First, Congress defined the term ``practitioner'' to mean ``a
physician . . . or other person licensed, registered, or otherwise
permitted, by . . . the jurisdiction in which he practices . . . ,
to distribute, dispense, . . . [or] administer . . . a controlled
substance in the course of professional practice.'' 21 U.S.C.
802(21). Second, in setting the requirements for obtaining a
practitioner's registration, Congress directed that ``[t]he Attorney
General shall register practitioners . . . if the applicant is
authorized to dispense . . . controlled substances under the laws of
the State in which he practices.'' 21 U.S.C. 823(g)(1). Because
Congress has clearly mandated that a practitioner possess state
authority in order to be deemed a practitioner under the CSA, DEA
has held repeatedly that revocation of a practitioner's registration
is the appropriate sanction whenever he is no longer authorized to
dispense controlled substances under the laws of the state in which
he practices. See, e.g., James L. Hooper, M.D., 76 FR 71371-72;
Sheran Arden Yeates, M.D., 71 FR 39130, 39131 (2006); Dominick A.
Ricci, M.D., 58 FR 51104, 51105 (1993); Bobby Watts, M.D., 53 FR
11919, 11920 (1988); Frederick Marsh Blanton, M.D., 43 FR 27617.
---------------------------------------------------------------------------
According to Colorado statute, ``dispense'' means ``to deliver a
controlled substance to an ultimate user,
[[Page 9170]]
patient, or research subject by or pursuant to the lawful order of a
practitioner, including the prescribing, administering, packaging,
labeling, or compounding necessary to prepare the substance for that
delivery.'' Colo. Rev. Stat. section 18-18-102(9) (2024). Further, a
``practitioner'' means a ``physician . . . or other person licensed,
registered, or otherwise permitted, by this state, to distribute,
dispense, conduct research with respect to, administer, or to use in
teaching or chemical analysis, a controlled substance in the course of
professional practice or research.'' Id. section 18-18-102(29).
Here, the undisputed evidence in the record is that Registrant
lacks authority to practice as a dentist in Colorado. As discussed
above an individual must be a licensed practitioner to dispense a
controlled substance in Colorado. Thus, because Registrant lacks
authority to practice as a dentist in Colorado and, therefore, is not
authorized to handle controlled substances in Colorado, Registrant is
not eligible to maintain a DEA registration. Accordingly, the Agency
will order that Registrant's DEA registration be revoked.
Order
Pursuant to 28 CFR 0.100(b) and the authority vested in me by 21
U.S.C. 824(a), I hereby revoke DEA Certificate of Registration No.
FC0032348, issued to James T. Craig, D.D.S. Further, pursuant to 28 CFR
0.100(b) and the authority vested in me by 21 U.S.C. 823(g)(1), I
hereby deny any pending applications of James T. Craig, D.D.S., to
renew or modify this registration, as well as any other pending
application of James T. Craig, D.D.S., for additional registration in
Colorado. This Order is effective March 10, 2025.
Signing Authority
This document of the Drug Enforcement Administration was signed on
January 31, 2025, by Acting Administrator Derek Maltz. That document
with the original signature and date is maintained by DEA. For
administrative purposes only, and in compliance with requirements of
the Office of the Federal Register, the undersigned DEA Federal
Register Liaison Officer has been authorized to sign and submit the
document in electronic format for publication, as an official document
of DEA. This administrative process in no way alters the legal effect
of this document upon publication in the Federal Register.
Heather Achbach,
Federal Register Liaison Officer, Drug Enforcement Administration.
[FR Doc. 2025-02341 Filed 2-6-25; 8:45 am]
BILLING CODE 4410-09-P